Cooperative roles of NF-κB and NFAT4 in polyomavirus JC regulation at the KB control element

Virology

Volumn 432, Issue 1, 2012, Pages 146-154

  Wollebo, Hassen S ^a   Melis, Sonia ^a   Khalili, Kamel ^a   Safak, Mahmut ^a   White, Martyn K ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

NF kappaB signaling; NFAT signaling; Polyomavirus JC; Progressive multifocal leukoencephalopathy

Indexed keywords

CALCINEURIN; CCAAT ENHANCER BINDING PROTEIN BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR NFAT4; UNCLASSIFIED DRUG; VIRUS DNA;

ARTICLE; CONTROLLED STUDY; DNA REPLICATION; GENETIC REGULATION; HUMAN; HUMAN CELL; JC VIRUS; KB CONTROL ELEMENT; LATENT PERIOD; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; VIRUS ACTIVATION; VIRUS REACTIVATION; VIRUS TRANSCRIPTION;

CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, VIRAL; HOST-PATHOGEN INTERACTIONS; HUMANS; JC VIRUS; NF-KAPPA B; NFATC TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION; VIRUS ACTIVATION; VIRUS REPLICATION;

JC POLYOMAVIRUS;

EID: 84863995116     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2012.06.010     Document Type: Article

References (63)

1. Aramburu J., Yaffe M.B., López-Rodríguez C., Cantley L.C., Hogan P.G., Rao A. Affinity-driven peptide selection of an NFAT inhibitor more selective than cyclosporin A. Science 1999, 285:2129-2133.
2. Beals C.R., Sheridan C.M., Turck C.W., Gardner P., Crabtree G.R. Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3. Science 1997, 275:1930-1934.
3. Benveniste E.N. Cytokine circuits in brain. Implications for AIDS dementia complex. Res. Publ. Assoc. Res. Nerv. Ment. Dis. 1994, 72:71-88.
4. Berger J.R. Progressive multifocal leukoencephalopathy. Curr. Neurol. Neurosci. Rep. 2007, 7:461-469.
5. Berger J.R., Concha M. Progressive multifocal leukoencephalopathy: the evolution of a disease once considered rare. J. Neurovirol 1995, 1:5-18.
6. Berger J.R. The basis for modeling progressive multifocal leukoencephalopathy pathogenesis. Curr. Opin. Neurol 2011, 24:262-267.
7. Clifford D.B., Ances B., Costello C., Rosen-Schmidt S., Andersson M., Parks D., Perry A., Yerra R., Schmidt R., Alvarez E., Tyler K.L. Rituximab-associated progressive multifocal leukoencephalopathy in rheumatoid arthritis. Arch. Neurol. 2011, 68:1156-1164.
8. Clipstone N.A., Crabtree G.R. Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation. Nature 1992, 357:695-697.
9. Coiras M., López-Huertas M.R., Pérez-Olmeda M., Alcamí J. Understanding HIV-1 latency provides clues for the eradication of long-term reservoirs. Nat. Rev. Microbiol. 2009, 7:798-812.
10. Daniel A.M., Swenson J.J., Mayreddy R.P., Khalili K., Frisque R.J. Sequences within the early and late promoters of archetype JC virus restrict viral DNA replication and infectivity. Virology 1996, 216:90-101.
11. Del Valle L., Gordon J., Enam S., Delbue S., Croul S., Abraham S., Radhakrishnan S., Assimakopoulou M., Katsetos C.D., Khalili K. Expression of human neurotropic polyomavirus JCV late gene product agnoprotein in human medulloblastoma. J. Natl. Cancer Inst. 2002, 94:267-273.
12. D'Souza A., Wilson J., Mukherjee S., Jaiyesimi I. Progressive multifocal leukoencephalopathy in chronic lymphocytic leukemia: a report of three cases and review of the literature. Clin. Lymphoma Myeloma Leuk. 2010, 10:E1-9.
13. Elsner C., Dorries K. Evidence of human polyomavirus BK and JC infection in normal brain tissue. Virology 1992, 191:72-80.
14. 2+/calcineurin signalling in cells of the immune system. Biochem. Biophys. Res. Commun. 2003, 311:1117-1132.
15. Frisque R.J., Bream G.L., Cannella M.T. Human polyomavirus JC virus genome. J. Virol. 1984, 51:458-469.
16. Graef I.A., Chen F., Crabtree G.R. NFAT signaling in vertebrate development. Curr. Opin. Genet. Dev. 2001, 11:505-512.
17. Graef I.A., Mermelstein P.G., Stankunas K., Neilson J.R., Deisseroth K., Tsien R.W., Crabtree G.R. L-type calcium channels and GSK-3 regulate the activity of NF-ATc4 in hippocampal neurons. Nature 1999, 401:703-708.
18. Greenlee J.E., Clawson S.A., Carney H.C., O-Neill F.J. Detection of JC virus early region sequences of brains of individuals without progressive multifocal leukoencephalopathy. Ann. Neurol. 2005, 28(S9):S61.
19. Ho A.M., Jain J., Rao A., Hogan P.G. Expression of the transcription factor NFATp in a neuronal cell line and in the murine nervous system. J. Biol. Chem. 1994, 269:28181-28186.
20. Imperiale M.J., Major E.O. Polyomaviruses. Fields Virology. Fifth Edition 2007, 2263-2298. Lippincott, Williams & Wilkins, Philadelphia. D.M. Knipe, P.M. Howley (Eds.).
21. Kaul M., Zheng J., Okamoto S., Gendelman H.E., Lipton S.A. HIV-1 infection and AIDS: consequences for the central nervous system. Cell Death Differ. 2005, 12(Suppl. 1):878-892.
22. Khalili K., White M.K., Lublin F., Ferrante P., Berger J.R. Reactivation of JC virus and development of PML in patients with multiple sclerosis. Neurology 2007, 68:985-990.
23. Khalili K., Safak M., Del Valle L., White M.K. JC virus molecular biology and the human demyelinating disease, progressive multifocal leukoencephalopathy. Neurotropic virus infections 2008, 190-211. Cambridge University Press, Cambridge, UK. C. Shoshkes Reiss (Ed.).
24. Kinoshita S., Su L., Amano M., Timmerman L.A., Kaneshima H., Nolan G.P. The T cell activation factor NF-ATc positively regulates HIV-1 replication and gene expression in T cells. Immunity 1997, 6:235-244.
25. Kleinschmidt-DeMasters B.K., Tyler K.L. Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis. N. Engl. J. Med. 2005, 353:369-374.
26. Kothary N., Diak I.L., Brinker A., Bezabeh S., Avigan M., Pan G.D. Progressive multifocal leukoencephalopathy associated with efalizumab use in psoriasis patients. J. Am. Acad. Dermatol. 2011, 65:546-551.
27. Kumar D. Emerging viruses in transplantation. Curr. Opin. Infect. Dis. 2010, 23:374-378.
28. Langer-Gould A., Atlas S.W., Green A.J., Bollen A.W., Pelletier D. Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. N. Engl. J. Med. 2005, 353:375-381.
29. Li H., Rao A., Hogan P.G. Interaction of calcineurin with substrates and targeting proteins. Trends Cell Biol. 2011, 21:91-103.
30. López-Huertas M.R., Callejas S., Abia D., Mateos E., Dopazo A., Alcamí J., Coiras M. Modifications in host cell cytoskeleton structure and function mediated by intracellular HIV-1 Tat protein are greatly dependent on the second coding exon. Nucleic Acids Res. 2010, 38:3287-3307.
31. Mahlknecht U., Dichamp I., Varin A., Van Lint C., Herbein G. NF-kappaB-dependent control of HIV-1 transcription by the second coding exon of Tat in T cells. J. Leukoc. Biol. 2008, 83:718-727.
32. Manley K., O'Hara B.A., Gee G.V., Simkevich C.P., Sedivy J.M., Atwood W.J. NFAT4 is required for JC virus infection of glial cells. J. Virol. 2006, 80:12079-12085.
33. Mateen F.J., Muralidharan R., Carone M., van de Beek D., Harrison D.M., Aksamit A.J., Gould M.S., Clifford D.B., Nath A. Progressive multifocal leukoencephalopathy in transplant recipients. Ann. Neurol. 2011, 70:305-322.
34. Mayreddy R.P., Safak M., Razmara M., Zoltick P., Khalili K. Transcription of the JC virus archetype late genome: importance of the kappa B and the 23-base-pair motifs in late promoter activity in glial cells. J. Virol. 1996, 70:2387-2393.
35. Mori M., Kurata H., Tajima M., Shimada H. JC virus detection by in situ hybridization in brain tissue from elderly patients. Ann. Neurol. 1991, 29:428-432.
36. Mori M., Aoki N., Shimada H., Tajima M., Kato K. Detection of JC virus in the brains of aged patients without progressive multifocal leukoencephalopathy by the polymerase chain reaction and Southern hybridization analysis. Neurosci. Lett. 1992, 141:151-155.
37. Mosieniak G., Pyrzynska B., Kaminska B. Nuclear factor of activated T cells (NFAT) as a new component of the signal transduction pathway in glioma cells. J. Neurochem. 1998, 71:134-141.
38. Padgett B.L., Zu Rhein G.M., Walker D.L., Echroade R., Dessel B. Cultivation of papova-like virus from human brain with progressive multifocal leukoencephalopathy. Lancet. 1971, 1257-1260.
39. Perez-Liz G., Del Valle L., Gentilella A., Croul S., Khalili K. Detection of JC virus DNA fragments but not proteins in normal brain tissue. Ann. Neurol. 2008, 64:379-387.
40. Pessler F., Cron R.Q. Reciprocal regulation of the nuclear factor of activated T cells and HIV-1. Genes Immun. 2004, 5:158-167.
41. Ranganathan P.N., Khalili K. The transcriptional enhancer element, kappa B, regulates promoter activity of the human neurotropic virus, JCV, in cells derived from the CNS. Nucleic Acids Res. 1993, 21:1959-1964.
42. Romagnoli L., Wollebo H.S., Deshmane S.L., Mukerjee R., Del Valle L., Safak M., Khalili K., White M.K. Modulation of JC virus transcription by C/EBPΒ. Virus Res. 2009, 146:97-106.
43. Safak M., Gallia G.L., Khalili K. A 23bp sequence element from human neurotrophic JC virus is responsive to NF-kappa B subunits. Virology 1999, 262:178-189.
44. Seiferth, A., Ruhs, S., Mildenberger, S., Gekle, M., Grossmann, C., 2012. The phosphatase calcineurin PP2BAΒ mediates part of mineralocorticoid receptor transcriptional activity. FASEB J. (in press).
45. Shibasaki F., Price E.R., Milan D., McKeon F. Role of kinases and the phosphatase calcineurin in the nuclear shuttling of transcription factor NF-AT4. Nature 1996, 382:370-373.
46. Shibasaki F., Hallin U., Uchino H. Calcineurin as a multifunctional regulator. J. Biochem. 2002, 131:1-15.
47. Sica A., Dorman L., Viggiano V., Cippitelli M., Ghosh P., Rice N., Young H.A. Interaction of NF-κB and NFAT with the interferon-gamma promoter. J. Biol. Chem. 1997, 272:30412-30420.
48. Stevenson A.S., Gomez M.F., Hill-Eubanks D.C, Nelson M.T. NFAT4 movement in native smooth muscle. A role for differential Ca(2+) signaling. J. Biol. Chem. 2001, 276:15018-15024.
49. Tada H., Rappaport J., Lashgari M., Amini S., Wong-Staal F., Khalili K. Trans-activation of the JC virus late promoter by the tat protein of type 1 human immunodeficiency virus in glial cells. Proc. Natl. Acad. Sci. USA 1990, 87:3479-3483.
50. Tan C.S., Ellis L.C., Wüthrich C., Ngo L., Broge T.A., Saint-Aubyn J., Miller J.S., Koralnik I.J. JC virus latency in the brain and extraneural organs of patients with and without progressive multifocal leukoencephalopathy. J. Virol. 2010, 84:9200-9209.
51. Taylor J.P., Pomerantz R., Bagasra O., Chowdhury M., Rappaport J., Khalili K., Amini S. TAR-independent transactivation by Tat in cells derived from the CNS: a novel mechanism of HIV-1 gene regulation. EMBO J. 1992, 11:3395-3403.
52. Vacca A., Farina M., Maroder M., Alesse E., Screpanti I., Frati L., Gulino A. Human immunodeficiency virus type-1 tat enhances interleukin-2 promoter activity through synergism with phorbol ester and calcium-mediated activation of the NF-AT cis-regulatory motif. Biochem. Biophys. Res. Commun. 1994, 205:467-474.
53. Van Assche G., Van Ranst M., Sciot R., Dubois B., Vermeire S., Noman M., Verbeeck J., Geboes K., Robberecht W., Rutgeerts P. Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease. N. Engl. J. Med. 2005, 353:362-368.
54. Vihma H., Pruunsild P., Timmusk T. Alternative splicing and expression of human and mouse NFAT genes. Genomics 2008, 92:279-291.
55. Wesselingh S.L., Power C., Glass J.D., Tyor W.R., McArthur J.C., Farber J.M., Griffin J.W., Griffin D.E. Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia. Ann. Neurol. 1993, 33:576-582.
56. White F.A., Ishaq M., Stoner G.L., Frisque R.J. JC virus DNA is present in many human brain samples from patients without progressive multifocal leukoencephalopathy. J. Virol. 1992, 66:5726-5734.
57. White M.K., Khalili K. Pathogenesis of progressive multifocal leukoencephalopathy - revisited. J. Infect. Dis. 2011, 203:578-586.
58. White M.K., Skowronska A., Gordon J., Del Valle L., Deshmane S.L., Giordano A., Croul S., Khalili K. Analysis of a mutant p53 protein arising in a medulloblastoma from a mouse transgenic for the JC virus early region. Anticancer Res. 2006, 26:4079-4092.
59. Wollebo H.S., Safak M., Del Valle L., Khalili K., White M.K. Role for tumor necrosis factor-alpha in JC virus reactivation and progressive multifocal leukoencephalopathy. J. Neuroimmunol. 2011, 233:46-53.
60. Xue J., Thippegowda P.B., Hu G., Bachmaier K., Christman J.W., Malik A.B., Tiruppathi C. NF-κB regulates thrombin-induced ICAM-1 gene expression in cooperation with NFAT by binding to the intronic NF-κB site in the ICAM-1 gene. Physiol. Genomics 2009, 38:42-53.
61. Yarilina A., Xu K., Chen J., Ivashkiv L.B. TNF activates calcium-nuclear factor of activated T cells (NFAT)c1 signaling pathways in human macrophages. Proc. Natl. Acad. Sci. USA 2008, 108:1573-1578.
62. Yeung M.C., Pulliam L., Lau A.S. The HIV envelope protein gp120 is toxic to human brain-cell cultures through the induction of interleukin-6 and tumor necrosis factor-alpha. AIDS 1995, 9:137-143.
63. Ziegler K., Bui T., Frisque R.J., Grandinetti A., Nerurkar V.R. A rapid in vitro polyomavirus DNA replication assay. J. Virol. Methods 2004, 122:123-127.